INM Financials

Inmed Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$0.71

Market Cap

$2.35M

EPS

$-2.88

Income Statement Highlights

Most Recent Quarter: 2025-06-30

Revenue

$4.94M

Gross Profit

Operating Income

Net Income

$-8.16M

EPS (Diluted)

$-8.36

Balance Sheet Highlights

Total Assets

$15.58M

Total Liabilities

$2.15M

Shareholders Equity

Cash & Equivalents

$11.08M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-7.77M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

29.7%

Operating Margin

-2.6%

Net Margin

-1.7%

ROE

-1.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is INM revenue?

INM's most recent quarterly revenue was $4.94M. Annual revenue can be calculated by summing the four most recent quarters.

Is INM profitable?

INM reported a loss of $8.16M in the most recent quarter. The net profit margin is -1.7%.

What is INM market cap?

INM has a market capitalization of $2.35M, making it a small-cap stock.

Does INM have debt?

View INM's balance sheet for debt information.

What is INM cash flow?

Cash flow data is available in the full financial statements.